VAISHALI vs ZOTA: Stock Comparison

Vaishali Pharma Ltd vs Zota Health Care LtdUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Zota Health Care Ltd is the larger company by market capitalisation. Vaishali Pharma Ltd shows a higher ROE, lower leverage and a higher net margin, while Zota Health Care Ltd shows a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VAISHALI leads 5; ZOTA leads 3 of 8

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VAISHALIZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹105 Cr
₹3,737 Cr
P/E RatioSame reading
-35.61x
P/B RatioSame reading
5.44x
EPSVAISHALI has the higher reading
₹0.32
₹-30.6
Book ValueContext only
₹5.3
₹200
Dividend YieldZOTA has the higher reading
0%
0.09%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹3,737 Cr vs ₹105 Cr
EPS
VAISHALI has higher earnings per share
₹0.32 vs ₹-30.6
Dividend Yield
ZOTA has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 18.35%
EPS Growth (TTM YoY)
ZOTA has faster EPS growth
0% vs -76.71%
ROE
VAISHALI has a higher ROE
6.02% vs -15%
Net Margin
VAISHALI has a higher net margin
3.83% vs -13.98%
Operating Margin
VAISHALI has a higher operating margin
3.78% vs 0.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVAISHALIZOTA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVAISHALIZOTA
Live Price₹7.97₹1,076.8
Day Change-1.85%-1.62%
Volume93,6071.1 L
52-Week High₹12.75₹1,740
52-Week Low₹4.75₹1,026.2
Distance from 52W High-37.49%-38.11%

Valuation

MetricVAISHALIZOTA
Market Cap₹105 Cr₹3,737 Cr
P/E Ratio-35.61x
P/B Ratio5.44x
EPS₹0.32₹-30.6
Book Value₹5.3₹200
Dividend Yield0%0.09%

Growth

MetricVAISHALIZOTA
Revenue Growth (TTM YoY)18.35%67.7%
EPS Growth (TTM YoY)-76.71%0%
Qtr Sales Growth67.6%
Qtr Profit Growth-204%

Profitability & Leverage

MetricVAISHALIZOTA
ROE6.02%-15%
ROCE-8.47%
Net Margin3.83%-13.98%
Operating Margin3.78%0.49%
Debt to Equity0.27x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricVAISHALIZOTA
Promoter Holding31.61%49.38%
FII Holding0%7.92% 0.29 pp
DII Holding0%6.75% 0.35 pp
Public Holding68.39%35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Vaishali Pharma Ltd and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.